{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:49Z","timestamp":1792788349496,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000849","name":"National Centre for the Replacement, Refinement and Reduction of Animals in Research","doi-asserted-by":"publisher","award":["NC3R Fellowship to S.A.L (NC\/T002336\/1)"],"award-info":[{"award-number":["NC3R Fellowship to S.A.L (NC\/T002336\/1)"]}],"id":[{"id":"10.13039\/501100000849","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000305","name":"Sight Research UK","doi-asserted-by":"publisher","award":["Seed award and PhD studentship"],"award-info":[{"award-number":["Seed award and PhD studentship"]}],"id":[{"id":"10.13039\/501100000305","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Gift of Sight Appeal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Age-related macular degeneration (AMD) is the commonest cause of irreversible blindness in developed societies. AMD coincides with advanced age to which genetic and lifestyle factors contribute additional risks. High levels of the Alzheimer\u2019s-linked Amyloid beta (A\u03b2) proteins are correlated with aged\/AMD retinas. To delineate the role of A\u03b2 in retinopathy from age-related changes, we used transgenic 5xFAD mice in a longitudinal study to recapitulate the aged\/AMD A\u03b2-burden of the human retina.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Mice were genotyped to exclude the retinal degeneration alleles\n                      <jats:italic>Pde6b<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>rd1<\/jats:italic>\n                      <\/jats:sup>\n                      ,\n                      <jats:italic>Pde6brd8<\/jats:italic>\n                      ,\n                      <jats:italic>Agouti<\/jats:italic>\n                      ,\n                      <jats:italic>Tyr<\/jats:italic>\n                      and\n                      <jats:italic>Oca2<\/jats:italic>\n                      . Retinas of 5xFAD and wildtype littermates (97 males\/females in total) were longitudinally assessed until 15 months using non-invasive retinal scans: multi-focal electroretinography, optokinetic tracking, optical coherence tomography (OCT), colour fundus photography and fluorescein angiography. Mice were killed at 4, 8 and 15 months, and eyes enucleated for analyses by light, confocal and electron microscopy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Age-related changes included a gradual decline of retinal activity in all mice. Subretinal\/drusen-like deposits increased with age, but, like retinal vessel morphology and vessel integrity, showed no differences between cohorts. Diminished PSD95 levels indicated impaired photoreceptor-bipolar connectivity which correlated with age. Ultrastructural imaging showed increased electron-dense granules and undigested outer segments within retinal pigment epithelial cells with age. 5xFAD pathology included significant weight reduction vs. wildtype\/littermates, which were pronounced in females. 8 month old 5xFAD mice had diminished A and B waves, though the age-related decline in wildtype mice abolished these subsequently. Visual acuity\/function was also reduced in 14 month 5xFAD eyes. OCT revealed thickened photoreceptor nuclei and inner segments in 8 month 5xFAD retinae. Scrutiny of chorioretinal tissues revealed diminished photoreceptor nuclei in 4 month 5xFAD eyes, though differences were abolished as both cohorts aged. From 8 months onwards, 5xFAD mice possessed fewer bipolar cell nuclei.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Chronic A\u03b2 exposure led to the earlier development of retinopathy-linked features, the identification of which advances our understanding of how A\u03b2 contributes to multifaceted retinopathies. These were distinguishable from wider age-related changes and non-specific influences of retinal degeneration alleles in 5xFAD mice. Longitudinal analyses revealed sex and age-related limitations and important 3Rs considerations for future studies using 5xFAD mice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-025-01784-w","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:55:03Z","timestamp":1750308903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A longitudinal study of the 5xFAD mouse retina delineates Amyloid beta (A\u03b2)-mediated retinal pathology from age-related changes"],"prefix":"10.1186","volume":"17","author":[{"given":"Savannah A.","family":"Lynn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha Priya Soundara","family":"Pandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Sanchez-Bretano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Marie","family":"Muir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Chatelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tutte","family":"Newall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise","family":"Keeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil R.","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay E.","family":"Self","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Lotery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Arjuna","family":"Ratnayaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"issue":"5","key":"1784_CR1","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1136\/bjophthalmol-2011-301109","volume":"96","author":"CG Owen","year":"2012","unstructured":"Owen CG, Jarrar Z, Wormald R, Cook DG, Fletcher AE, Rudnicka AR. The estimated prevalence and incidence of late stage age related macular degeneration in the UK. Br J Ophthalmol. 2012;96(5):752\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"1784_CR2","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106\u201316.","journal-title":"Lancet Glob Health"},{"key":"1784_CR3","first-page":"87","volume":"10","author":"P Hykin","year":"2016","unstructured":"Hykin P, Chakravarthy U, Lotery A, McKibbin M, Napier J, Sivaprasad S. A retrospective study of the real-life utilization and effectiveness of ranibizumab therapy for neovascular age-related macular degeneration in the UK. Clin Ophthalmol. 2016;10:87\u201396.","journal-title":"Clin Ophthalmol"},{"key":"1784_CR4","unstructured":"Fritsche LG, Igl W, Bailey JN, Grassmann F, Sengupta S, Bragg-Gresham JL, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2015."},{"issue":"5","key":"1784_CR5","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.3945\/ajcn.115.111047","volume":"102","author":"BM Merle","year":"2015","unstructured":"Merle BM, Silver RE, Rosner B, Seddon JM. Adherence to a mediterranean diet, genetic susceptibility, and progression to advanced macular degeneration: a prospective cohort study. Am J Clin Nutr. 2015;102(5):1196\u20131206.","journal-title":"Am J Clin Nutr"},{"key":"1784_CR6","doi-asserted-by":"crossref","unstructured":"de Koning-Backus APM, Kiefte-de Jong JC, van Rooij JGJ, Amd-Life T, Uitterlinden AG, Voortman TG, et al. Lifestyle intervention randomized controlled trial for age-related macular degeneration (AMD-Life): study design. Nutrients. 2023;15(3):602.","DOI":"10.3390\/nu15030602"},{"issue":"10","key":"1784_CR7","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, et al. The Amyloid-\u03b2 Pathway in Alzheimer\u2019s Disease. Mol Psychiatry. 2021;26(10):5481\u2013503.","journal-title":"Mol Psychiatry"},{"issue":"4","key":"1784_CR8","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4103\/1673-5374.205083","volume":"12","author":"SA Lynn","year":"2017","unstructured":"Lynn SA, Keeling E, Munday R, Gabha G, Griffiths H, Lotery AJ, et al. The complexities underlying age-related macular degeneration: could amyloid beta play an important role? Neural Regen Res. 2017;12(4):538\u201348.","journal-title":"Neural Regen Res"},{"issue":"2","key":"1784_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.exer.2003.10.011","volume":"78","author":"DH Anderson","year":"2004","unstructured":"Anderson DH, Talaga KC, Rivest AJ, Barron E, Hageman GS, Johnson LV. Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp Eye Res. 2004;78(2):243\u201356.","journal-title":"Exp Eye Res"},{"issue":"18","key":"1784_CR10","doi-asserted-by":"publisher","first-page":"11830","DOI":"10.1073\/pnas.192203399","volume":"99","author":"LV Johnson","year":"2002","unstructured":"Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH. The Alzheimer\u2019s A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci U S A. 2002;99(18):11830\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1784_CR11","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1172\/JCI25843","volume":"116","author":"V Luibl","year":"2006","unstructured":"Luibl V, Isas JM, Kayed R, Glabe CG, Langen R, Chen J. Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. J Clin Invest. 2006;116(2):378\u201385.","journal-title":"J Clin Invest"},{"issue":"3","key":"1784_CR12","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1167\/iovs.09-4207","volume":"51","author":"JM Isas","year":"2010","unstructured":"Isas JM, Luibl V, Johnson LV, Kayed R, Wetzel R, Glabe CG, et al. Soluble and mature amyloid fibrils in drusen deposits. Invest Ophthalmol Vis Sci. 2010;51(3):1304\u201310.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1784_CR13","first-page":"184","volume":"9","author":"T Dentchev","year":"2003","unstructured":"Dentchev T, Milam AH, Lee VM, Trojanowski JQ, Dunaief JL. Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Mol Vis. 2003;9:184\u201390.","journal-title":"Mol Vis"},{"issue":"8","key":"1784_CR14","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s00417-015-2970-x","volume":"253","author":"R Guymer","year":"2015","unstructured":"Guymer R, Cipriani T, Rittenhouse KD, Lim L, Robman LD, Li W, et al. Plasma levels of amyloid beta and other proinflammatory mediators in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2015;253(8):1347\u201354.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1\u20132","key":"1784_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/08820538.2021.1883679","volume":"36","author":"J Zhu","year":"2021","unstructured":"Zhu J, Su T, Wang M, Li M, Liu L, Wang F. Highly Expressed Amyloid Beta-42 Of Aqueous Humor In Patients With Neovascular Macular Degeneration. Semin Ophthalmol. 2021;36(1\u20132):9\u201313.","journal-title":"Semin Ophthalmol"},{"issue":"4","key":"1784_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-023-02548-2","volume":"145","author":"Y Koronyo","year":"2023","unstructured":"Koronyo Y, Rentsendorj A, Mirzaei N, Regis GC, Sheyn J, Shi H, et al. Retinal pathological features and proteome signatures of Alzheimer\u2019s disease. Acta Neuropathol. 2023;145(4):409\u201338.","journal-title":"Acta Neuropathol"},{"key":"1784_CR17","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3389\/fnins.2020.00758","volume":"14","author":"S Lee","year":"2020","unstructured":"Lee S, Jiang K, McIlmoyle B, To E, Xu QA, Hirsch-Reinshagen V, et al. Amyloid Beta Immunoreactivity in the Retinal Ganglion Cell Layer of the Alzheimer\u2019s Eye. Front Neurosci. 2020;14:758.","journal-title":"Front Neurosci"},{"issue":"40","key":"1784_CR18","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129\u201340.","journal-title":"J Neurosci"},{"key":"1784_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.exer.2015.06.027","volume":"138","author":"R Parthasarathy","year":"2015","unstructured":"Parthasarathy R, Chow KM, Derafshi Z, Fautsch MP, Hetling JR, Rodgers DW, et al. Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin. Exp Eye Res. 2015;138:134\u201344.","journal-title":"Exp Eye Res"},{"key":"1784_CR20","doi-asserted-by":"crossref","unstructured":"Lynn SA, Johnston DA, Scott JA, Munday R, Desai RS, Keeling E, et al. Oligomeric A\u03b2(1\u201342) Induces an AMD-Like phenotype and accumulates in lysosomes to impair rpe function. Cells. 2021;10(2):413.","DOI":"10.3390\/cells10020413"},{"key":"1784_CR21","doi-asserted-by":"crossref","unstructured":"Truett GE, Heeger P, Mynatt RL, Truett AA, Walker JA, Warman ML. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques. 2000;29(1):52, 4.","DOI":"10.2144\/00291bm09"},{"issue":"1","key":"1784_CR22","doi-asserted-by":"publisher","first-page":"17173","DOI":"10.1038\/s41598-023-44373-3","volume":"13","author":"A Sanchez-Bretano","year":"2023","unstructured":"Sanchez-Bretano A, Keeling E, Scott JA, Lynn SA, Soundara-Pandi SP, Macdonald SL, et al. Human equivalent doses of L-DOPA rescues retinal morphology and visual function in a murine model of albinism. Sci Rep. 2023;13(1):17173.","journal-title":"Sci Rep"},{"key":"1784_CR23","doi-asserted-by":"crossref","unstructured":"Au - Dietrich M, Au - Hecker C, Au - Hilla A, Au - Cruz-Herranz A, Au - Hartung H-P, Au - Fischer D, et al. Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats. JoVE. 2019(143):e58571.","DOI":"10.3791\/58571"},{"issue":"13","key":"1784_CR24","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.1167\/iovs.19-26966","volume":"60","author":"J Xiao","year":"2019","unstructured":"Xiao J, Adil MY, Chang K, Yu Z, Yang L, Utheim TP, et al. Visual Contrast Sensitivity Correlates to the Retinal Degeneration in Rhodopsin Knockout Mice. Invest Ophthalmol Vis Sci. 2019;60(13):4196\u2013204.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"1784_CR25","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/pcmr.12782","volume":"32","author":"H Lee","year":"2019","unstructured":"Lee H, Scott J, Griffiths H, Self JE, Lotery A. Oral levodopa rescues retinal morphology and visual function in a murine model of human albinism. Pigment Cell Melanoma Res. 2019;32(5):657\u201371.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"7","key":"1784_CR26","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676\u201382.","journal-title":"Nat Methods"},{"issue":"10","key":"1784_CR27","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1097\/OPX.0000000000000941","volume":"93","author":"OJ Mezu-Ndubuisi","year":"2016","unstructured":"Mezu-Ndubuisi OJ. In Vivo Angiography Quantifies Oxygen-Induced Retinopathy Vascular Recovery. Optom Vis Sci. 2016;93(10):1268\u201379.","journal-title":"Optom Vis Sci"},{"key":"1784_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-62703-080-9_2","volume":"935","author":"B Chang","year":"2013","unstructured":"Chang B. Mouse models for studies of retinal degeneration and diseases. Methods Mol Biol. 2013;935:27\u201339.","journal-title":"Methods Mol Biol"},{"issue":"4","key":"1784_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/gbb.12794","volume":"21","author":"TP O'Leary","year":"2022","unstructured":"O\u2019Leary TP, Brown RE. Visuo-spatial learning and memory impairments in the 5xFAD mouse model of Alzheimer\u2019s disease: Effects of age, sex, albinism, and motor impairments. Genes Brain Behav. 2022;21(4): e12794.","journal-title":"Genes Brain Behav"},{"issue":"7618","key":"1784_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussi\u00e8re T, Weinreb PH, Williams L, Maier M, et al. The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature. 2016;537(7618):50\u20136.","journal-title":"Nature"},{"issue":"1","key":"1784_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in Early Alzheimer\u2019s Disease. N Engl J Med. 2023;388(1):9\u201321.","journal-title":"N Engl J Med"},{"issue":"6","key":"1784_CR32","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, et al. Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA. 2023;330(6):512\u201327.","journal-title":"JAMA"},{"issue":"7","key":"1784_CR33","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/nan.12642","volume":"46","author":"D Boche","year":"2020","unstructured":"Boche D, Nicoll JAR. Invited Review - Understanding cause and effect in Alzheimer\u2019s pathophysiology: Implications for clinical trials. Neuropathol Appl Neurobiol. 2020;46(7):623\u201340.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1784_CR34","doi-asserted-by":"crossref","unstructured":"Nam Y, Kim S, Kim J, Hoe HS, Moon M. Mesoscopic mapping of visual pathway in a female 5XFAD mouse model of Alzheimer's disease. Cells. 2022;11(23):3901.","DOI":"10.3390\/cells11233901"},{"key":"1784_CR35","unstructured":"Lynn SA, Goverdhan S, Munday R, Scott J, Freeman T, Johnston D, et al. A mouse model to study A\u03b2-driven pathology in the ageing retina. Investigative Ophthalmology & Visual Science. 2016;57(12):6534-."},{"key":"1784_CR36","doi-asserted-by":"crossref","unstructured":"Ratnayaka JA, Lynn S. Alzheimer\u2019s-Related Amyloid Beta Peptide Aggregates in the Ageing Retina: Implications for Sight Loss and Dementia. 1 ed. D M, editor. Croatia: Intech Publishing; 2016 2016\u201309\u201328. 546 p.","DOI":"10.5772\/64790"},{"issue":"28","key":"1784_CR37","doi-asserted-by":"publisher","first-page":"E279","DOI":"10.1073\/pnas.1100901108","volume":"108","author":"JD Ding","year":"2011","unstructured":"Ding JD, Johnson LV, Herrmann R, Farsiu S, Smith SG, Groelle M, et al. Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proc Natl Acad Sci U S A. 2011;108(28):E279\u201387.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"48","key":"1784_CR38","doi-asserted-by":"publisher","first-page":"24317","DOI":"10.1073\/pnas.1912959116","volume":"116","author":"KV Do","year":"2019","unstructured":"Do KV, Kautzmann MI, Jun B, Gordon WC, Nshimiyimana R, Yang R, et al. Elovanoids counteract oligomeric beta-amyloid-induced gene expression and protect photoreceptors. Proc Natl Acad Sci U S A. 2019;116(48):24317\u201325.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1784_CR39","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/eye.2015.100","volume":"29","author":"JA Ratnayaka","year":"2015","unstructured":"Ratnayaka JA, Serpell LC, Lotery AJ. Dementia of the eye: the role of amyloid beta in retinal degeneration. Eye (Lond). 2015;29(8):1013\u201326.","journal-title":"Eye (Lond)"},{"key":"1784_CR40","doi-asserted-by":"crossref","unstructured":"Matei N, Leahy S, Blair NP, Burford J, Rahimi M, Shahidi M. Retinal vascular physiology biomarkers in a 5XFAD mouse model of Alzheimer's disease. Cells. 2022;11(15):2413.","DOI":"10.3390\/cells11152413"},{"key":"1784_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.681831","volume":"15","author":"M Zhang","year":"2021","unstructured":"Zhang M, Zhong L, Han X, Xiong G, Xu D, Zhang S, et al. Brain and Retinal Abnormalities in the 5xFAD Mouse Model of Alzheimer\u2019s Disease at Early Stages. Front Neurosci. 2021;15: 681831.","journal-title":"Front Neurosci"},{"key":"1784_CR42","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3389\/fnins.2020.00862","volume":"14","author":"JKH Lim","year":"2020","unstructured":"Lim JKH, Li QX, He Z, Vingrys AJ, Chinnery HR, Mullen J, et al. Retinal Functional and Structural Changes in the 5xFAD Mouse Model of Alzheimer\u2019s Disease. Front Neurosci. 2020;14:862.","journal-title":"Front Neurosci"},{"issue":"1","key":"1784_CR43","doi-asserted-by":"publisher","first-page":"4824","DOI":"10.1038\/s41598-021-84318-2","volume":"11","author":"JJ McAnany","year":"2021","unstructured":"McAnany JJ, Matei N, Chen YF, Liu K, Park JC, Shahidi M. Rod pathway and cone pathway retinal dysfunction in the 5xFAD mouse model of Alzheimer\u2019s disease. Sci Rep. 2021;11(1):4824.","journal-title":"Sci Rep"},{"issue":"3","key":"1784_CR44","doi-asserted-by":"publisher","DOI":"10.1117\/1.NPh.8.3.035002","volume":"8","author":"TH Kim","year":"2021","unstructured":"Kim TH, Son T, Klatt D, Yao X. Concurrent OCT and OCT angiography of retinal neurovascular degeneration in the 5XFAD Alzheimer\u2019s disease mice. Neurophotonics. 2021;8(3): 035002.","journal-title":"Neurophotonics"},{"key":"1784_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.902254","volume":"13","author":"N El-Darzi","year":"2022","unstructured":"El-Darzi N, Mast N, Buchner DA, Saadane A, Dailey B, Trichonas G, et al. Low-Dose Anti-HIV Drug Efavirenz Mitigates Retinal Vascular Lesions in a Mouse Model of Alzheimer\u2019s Disease. Front Pharmacol. 2022;13: 902254.","journal-title":"Front Pharmacol"},{"issue":"2","key":"1784_CR46","first-page":"358","volume":"35","author":"RN Lolley","year":"1994","unstructured":"Lolley RN, Rong H, Craft CM. Linkage of photoreceptor degeneration by apoptosis with inherited defect in phototransduction. Invest Ophthalmol Vis Sci. 1994;35(2):358\u201362.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1784_CR47","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0042-6989(01)00146-8","volume":"42","author":"B Chang","year":"2002","unstructured":"Chang B, Hawes NL, Hurd RE, Davisson MT, Nusinowitz S, Heckenlively JR. Retinal degeneration mutants in the mouse. Vision Res. 2002;42(4):517\u201325.","journal-title":"Vision Res"},{"issue":"2","key":"1784_CR48","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1034\/j.1600-0749.2001.140203.x","volume":"14","author":"MH Brilliant","year":"2001","unstructured":"Brilliant MH. The mouse p (pink-eyed dilution) and human P genes, oculocutaneous albinism type 2 (OCA2), and melanosomal pH. Pigment Cell Res. 2001;14(2):86\u201393.","journal-title":"Pigment Cell Res"},{"issue":"6","key":"1784_CR49","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1167\/iovs.03-0842","volume":"45","author":"A Bravo-Nuevo","year":"2004","unstructured":"Bravo-Nuevo A, Walsh N, Stone J. Photoreceptor Degeneration and Loss of Retinal Function in the C57BL\/6-C2J Mouse. Invest Ophthalmol Vis Sci. 2004;45(6):2005\u201312.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1784_CR50","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1016\/S0140-6736(17)30455-5","volume":"389","author":"H Lee","year":"2017","unstructured":"Lee H, Scott J, Griffiths H, Self JE, Lotery A. Comparison of mouse and human retinal morphology and function in albinism: potential implications for therapeutic development. The Lancet. 2017;389:S59.","journal-title":"The Lancet"},{"issue":"2","key":"1784_CR51","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1538\/expanim.14-0075","volume":"64","author":"H Shoji","year":"2015","unstructured":"Shoji H, Kiniwa Y, Okuyama R, Yang M, Higuchi K, Mori M. A nonsense nucleotide substitution in the oculocutaneous albinism II gene underlies the original pink-eyed dilution allele (Oca2(p)) in mice. Exp Anim. 2015;64(2):171\u20139.","journal-title":"Exp Anim"},{"key":"1784_CR52","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neurobiolaging.2018.03.017","volume":"67","author":"C Criscuolo","year":"2018","unstructured":"Criscuolo C, Cerri E, Fabiani C, Capsoni S, Cattaneo A, Domenici L. The retina as a window to early dysfunctions of Alzheimer\u2019s disease following studies with a 5xFAD mouse model. Neurobiol Aging. 2018;67:181\u20138.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1784_CR53","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41598-020-79424-6","volume":"11","author":"M Trinh","year":"2021","unstructured":"Trinh M, Khou V, Zangerl B, Kalloniatis M, Nivison-Smith L. Modelling normal age-related changes in individual retinal layers using location-specific OCT analysis. Sci Rep. 2021;11(1):558.","journal-title":"Sci Rep"},{"key":"1784_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108404","volume":"203","author":"SP Soundara Pandi","year":"2021","unstructured":"Soundara Pandi SP, Ratnayaka JA, Lotery AJ, Teeling JL. Progress in developing rodent models of age-related macular degeneration (AMD). Exp Eye Res. 2021;203: 108404.","journal-title":"Exp Eye Res"},{"issue":"9","key":"1784_CR55","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1136\/bjo.2008.153577","volume":"93","author":"NK Wang","year":"2009","unstructured":"Wang NK, Fine HF, Chang S, Chou CL, Cella W, Tosi J, et al. Cellular origin of fundus autofluorescence in patients and mice with a defective NR2E3 gene. Br J Ophthalmol. 2009;93(9):1234\u201340.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"1784_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173716","volume":"12","author":"H Huang","year":"2017","unstructured":"Huang H, Liu Y, Wang L, Li W. Age-related macular degeneration phenotypes are associated with increased tumor necrosis-alpha and subretinal immune cells in aged Cxcr5 knockout mice. PLoS ONE. 2017;12(3): e0173716.","journal-title":"PLoS ONE"},{"key":"1784_CR57","doi-asserted-by":"crossref","unstructured":"Jovanovic Macura I, Zivanovic A, Perovic M, Ciric J, Major T, Kanazir S, et al. The Expression of Major Facilitator Superfamily Domain-Containing Protein2a (Mfsd2a) and Aquaporin 4 Is Altered in the Retinas of a 5xFAD Mouse Model of Alzheimer's Disease. Int J Mol Sci. 2023;24(18):14092.","DOI":"10.3390\/ijms241814092"},{"key":"1784_CR58","unstructured":"Flurkey K, M. Currer J, Harrison DE. Chapter 20 - Mouse Models in Aging Research. In: Fox JG, Davisson MT, Quimby FW, Barthold SW, Newcomer CE, Smith AL, editors. The Mouse in Biomedical Research (Second Edition). Burlington: Academic Press; 2007. p. 637\u201372."},{"issue":"1","key":"1784_CR59","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41597-021-01054-y","volume":"8","author":"S Forner","year":"2021","unstructured":"Forner S, Kawauchi S, Balderrama-Gutierrez G, Kram\u00e1r EA, Matheos DP, Phan J, et al. Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer\u2019s disease. Sci Data. 2021;8(1):270.","journal-title":"Sci Data"},{"key":"1784_CR60","doi-asserted-by":"crossref","unstructured":"Barton SM, To E, Rogers BP, Whitmore C, Uppal M, Matsubara JA, et al. Inhalable thioflavin s for the detection of amyloid beta deposits in the retina. Molecules. 2021;26(4):835.","DOI":"10.3390\/molecules26040835"},{"issue":"9","key":"1784_CR61","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.neurobiolaging.2014.03.008","volume":"35","author":"SW Park","year":"2014","unstructured":"Park SW, Kim JH, Mook-Jung I, Kim KW, Park WJ, Park KH, et al. Intracellular amyloid beta alters the tight junction of retinal pigment epithelium in 5XFAD mice. Neurobiol Aging. 2014;35(9):2013\u201320.","journal-title":"Neurobiol Aging"},{"key":"1784_CR62","doi-asserted-by":"publisher","first-page":"1107436","DOI":"10.3389\/fnins.2023.1107436","volume":"17","author":"P Wijesinghe","year":"2023","unstructured":"Wijesinghe P, Whitmore CA, Campbell M, Li C, Tsuyuki M, To E, et al. Ergothioneine, a dietary antioxidant improves amyloid beta clearance in the neuroretina of a mouse model of Alzheimer\u2019s disease. Front Neurosci. 2023;17:1107436.","journal-title":"Front Neurosci"},{"key":"1784_CR63","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.exer.2016.10.013","volume":"153","author":"G Taylor-Walker","year":"2016","unstructured":"Taylor-Walker G, Lynn SA, Keeling E, Munday R, Johnston DA, Page A, et al. The Alzheimer\u2019s-related amyloid beta peptide is internalised by R28 neuroretinal cells and disrupts the microtubule associated protein 2 (MAP-2). Exp Eye Res. 2016;153:110\u201321.","journal-title":"Exp Eye Res"},{"issue":"25","key":"1784_CR64","doi-asserted-by":"publisher","first-page":"40006","DOI":"10.18632\/oncotarget.16967","volume":"8","author":"SW Park","year":"2017","unstructured":"Park SW, Im S, Jun HO, Lee K, Park YJ, Kim JH, et al. Dry age-related macular degeneration like pathology in aged 5XFAD mice: Ultrastructure and microarray analysis. Oncotarget. 2017;8(25):40006\u201318.","journal-title":"Oncotarget"},{"issue":"5","key":"1784_CR65","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1167\/iovs.61.5.35","volume":"61","author":"K Bermond","year":"2020","unstructured":"Bermond K, Wobbe C, Tarau IS, Heintzmann R, Hillenkamp J, Curcio CA, et al. Autofluorescent Granules of the Human Retinal Pigment Epithelium: Phenotypes, Intracellular Distribution, and Age-Related Topography. Invest Ophthalmol Vis Sci. 2020;61(5):35.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"1784_CR66","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1167\/iovs.13-11612","volume":"54","author":"L Cao","year":"2013","unstructured":"Cao L, Wang H, Wang F, Xu D, Liu F, Liu C. Abeta-induced senescent retinal pigment epithelial cells create a proinflammatory microenvironment in AMD. Invest Ophthalmol Vis Sci. 2013;54(5):3738\u201350.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"1784_CR67","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1474-9726.2009.00456.x","volume":"8","author":"J Bruban","year":"2009","unstructured":"Bruban J, Glotin AL, Dinet V, Chalour N, Sennlaub F, Jonet L, et al. Amyloid-beta(1\u201342) alters structure and function of retinal pigmented epithelial cells. Aging Cell. 2009;8(2):162\u201377.","journal-title":"Aging Cell"},{"issue":"34","key":"1784_CR68","doi-asserted-by":"publisher","first-page":"35263","DOI":"10.18632\/oncotarget.5894","volume":"6","author":"SW Park","year":"2015","unstructured":"Park SW, Kim JH, Park SM, Moon M, Lee KH, Park KH, et al. RAGE mediated intracellular Abeta uptake contributes to the breakdown of tight junction in retinal pigment epithelium. Oncotarget. 2015;6(34):35263\u201373.","journal-title":"Oncotarget"},{"key":"1784_CR69","unstructured":"Malagise E, Keeling E, Knezovich N, Waybright L, Watto E, Caggiano AO, et al. Sigma-2 receptor modulators rescue POS trafficking deficits in RPE cell-based models of dry AMD. Investigative Ophthalmology & Visual Science. 2022;63(7):3182 \u2013 F0456\u20133182 \u2013 F0456."},{"issue":"1","key":"1784_CR70","doi-asserted-by":"publisher","first-page":"4256","DOI":"10.1038\/s41598-025-87921-9","volume":"15","author":"BN Lizama","year":"2025","unstructured":"Lizama BN, Keeling E, Cho E, Malagise EM, Knezovich N, Waybright L, et al. Sigma-2 receptor modulator CT1812 alters key pathways and rescues retinal pigment epithelium (RPE) functional deficits associated with dry age-related macular degeneration (AMD). Sci Rep. 2025;15(1):4256.","journal-title":"Sci Rep"},{"key":"1784_CR71","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev-vision-112122-020950","volume":"9","author":"JD Zhu","year":"2023","unstructured":"Zhu JD, Tarachand SP, Abdulwahab Q, Samuel MA. Structure, Function, and Molecular Landscapes of the Aging Retina. Annu Rev Vis Sci. 2023;9:177\u201399.","journal-title":"Annu Rev Vis Sci"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01784-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01784-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01784-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T06:02:41Z","timestamp":1750312961000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01784-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1784"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01784-w","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"9 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Studies were overseen by the institutions\u2019 Animal Welfare and Ethical Review Board (AWERB) and were consistent with the Association for Research in Vision and Ophthalmology statement (ARVO) for the Use of Animals in Ophthalmic procedures and the UK Animal (Scientific Procedures) Act of 1986. The study complied with the ARRIVE guidelines with work undertaken under a UK Home Office project licence.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate\u00a0"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"136"}}